Literature DB >> 20831746

Interferon (IFN) beta treatment induces major histocompatibility complex (MHC) class I expression in the spinal cord and enhances axonal growth and motor function recovery following sciatic nerve crush in mice.

R G Zanon1, L P Cartarozzi, S C S Victório, J C Moraes, J Morari, L A Velloso, A L R Oliveira.   

Abstract

AIMS: Major histocompatibility complex (MHC) class I expression by neurones and glia constitutes an important pathway that regulates synaptic plasticity. The upregulation of MHC class I after treatment with interferon beta (IFN beta) accelerates the response to injury. Therefore the present work studied the regenerative outcome after peripheral nerve lesion and treatment with IFN beta, aiming at increasing MHC class I upregulation in the spinal cord.
METHODS: C57BL/6J mice were subjected to unilateral sciatic nerve crush and treatment with IFN beta. The lumbar spinal cords were processed for immunohistochemistry, in situ hybridization, Western blotting and RT-PCR, while the sciatic nerves were submitted for immunohistochemistry, morphometry and counting of regenerated axons. Motor function recovery was monitored using the walking track test.
RESULTS: Increased MHC class I expression in the motor nucleus of IFN beta-treated animals was detected. In the peripheral nerve, IFN beta-treated animals showed increased S100, GAP-43 and p75NTR labelling coupled with a significantly greater number of regenerated axons. No significant differences were found in neurofilament or laminin labelling. The morphological findings, indicating improvements in the regenerative process after IFN treatment were in line with the motor behaviour test applied to the animals during the recovery process.
CONCLUSIONS: The present data reinforce the role of MHC class I upregulation in the response to injury, and suggest that IFN treatment may be beneficial to motor recovery after axotomy.
© 2010 The Authors. Neuropathology and Applied Neurobiology © 2010 British Neuropathological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20831746     DOI: 10.1111/j.1365-2990.2010.01095.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  12 in total

1.  Transgenic mice with enhanced neuronal major histocompatibility complex class I expression recover locomotor function better after spinal cord injury.

Authors:  M Selvan Joseph; Tina Bilousova; Sharon Zdunowski; Zhongqi-Phyllis Wu; Blake Middleton; Maia Boudzinskaia; Bonnie Wong; Noore Ali; Hui Zhong; Jing Yong; Lorraine Washburn; Nathalie Escande-Beillard; Hoa Dang; V Reggie Edgerton; Niranjala J K Tillakaratne; Daniel L Kaufman
Journal:  J Neurosci Res       Date:  2010-12-22       Impact factor: 4.164

2.  Absence of IFNγ expression induces neuronal degeneration in the spinal cord of adult mice.

Authors:  Sheila C S Victório; Leif A Havton; Alexandre L R Oliveira
Journal:  J Neuroinflammation       Date:  2010-11-12       Impact factor: 8.322

3.  Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells.

Authors:  Shan Wan; Sidney Pestka; Ronald G Jubin; Yi Lisa Lyu; Yu-Chen Tsai; Leroy F Liu
Journal:  PLoS One       Date:  2012-03-01       Impact factor: 3.240

4.  Activation of cellular immunity and marked inhibition of liver cancer in a mouse model following gene therapy and tumor expression of GM-SCF, IL-21, and Rae-1.

Authors:  Mingrong Cheng; Kangkang Zhi; Xiaoyan Gao; Bing He; Yingchun Li; Jiang Han; Zhiping Zhang; Yan Wu
Journal:  Mol Cancer       Date:  2013-12-18       Impact factor: 27.401

Review 5.  Phagocytosis of microglia in the central nervous system diseases.

Authors:  Ruying Fu; Qingyu Shen; Pengfei Xu; Jin Jun Luo; Yamei Tang
Journal:  Mol Neurobiol       Date:  2014-01-07       Impact factor: 5.590

6.  MHC-I and PirB Upregulation in the Central and Peripheral Nervous System following Sciatic Nerve Injury.

Authors:  André Luis Bombeiro; Rodolfo Thomé; Sérgio Luiz Oliveira Nunes; Bárbara Monteiro Moreira; Liana Verinaud; Alexandre Leite Rodrigues de Oliveira
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

7.  Transcriptomic profiling of microglia reveals signatures of cell activation and immune response, during experimental cerebral malaria.

Authors:  Barbara Capuccini; Jingwen Lin; Carlos Talavera-López; Shahid M Khan; Jan Sodenkamp; Roberta Spaccapelo; Jean Langhorne
Journal:  Sci Rep       Date:  2016-12-19       Impact factor: 4.379

8.  Decreased MHC I expression in IFN γ mutant mice alters synaptic elimination in the spinal cord after peripheral injury.

Authors:  Sheila C S Victório; Luciana P Cartarozzi; Rafaela C R Hell; Alexandre L R Oliveira
Journal:  J Neuroinflammation       Date:  2012-05-07       Impact factor: 8.322

9.  Toll-like receptor signaling adapter proteins govern spread of neuropathic pain and recovery following nerve injury in male mice.

Authors:  Jennifer A Stokes; Jonathan Cheung; Kelly Eddinger; Maripat Corr; Tony L Yaksh
Journal:  J Neuroinflammation       Date:  2013-12-09       Impact factor: 8.322

10.  Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.

Authors:  Mingrong Cheng; Hongzhi Xu; Yong Wang; Houxiang Chen; Bing He; Xiaoyan Gao; Yingchun Li; Jiang Han; Zhiping Zhang
Journal:  Drug Des Devel Ther       Date:  2013-10-25       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.